M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Jazz Pharmaceuticals plc to acquire Actio Biosciences, Inc.
Announced Aug 10, 2026 · Closed Sep 15, 2026 · Private target
Deal value$820M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Jazz Pharmaceuticals plc (JAZZ)
- Target
- Actio Biosciences, Inc.
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Sep 15, 2026
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Moelis
- To the target
- JPMorgan, Centerview
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations